Bright Minds Biosciences, Inc. (DRUG.CX)

108.64 -2.39 (-2.15%) CAD  |  CNSX  |  Mar 03, 15:48
More

Bright Minds Biosciences EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for DRUG.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Fennec Pharmaceuticals, Inc. Upgrade
Green Thumb Industries, Inc. Upgrade
Lowell Farms, Inc. --
Wesana Health Holdings, Inc. --
Sharp Therapeutics Corp. --